Skip to main content

Table 1 Baseline characteristics of 27 patients with BCLM

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

Clinical features Value
Average age (years) (range) 55.17 ± 9.06 (33–79)
 60 years 21
  ≥ 60 years 6
Menstrual state
 Premenopausal 9
 Postmenopausal 18
Pathological subtype
 Invasive ductal carcinoma 26
 Invasive lobular carcinoma 1
Primary tumor size (cm)
 2 15
 2–5 6
  ≥ 5 5
 Invasion of chest wall skin 1
Axillary metastatic lymph nodes (number)
 0 14
 1–34 8
  ≥ 4 5
ER/PR
  +  18
  −  9
Her-2
  +  15
  −  12
Time to postoperative liver metastasis (months)
  < 24 16
  ≥ 24 11
Intrahepatic lesions (number)
 Single 5
 Multiple 22
Intrahepatic lesion size (cm)
 3 3
 ≥ 3 24
Whether combination therapy was adopted
 Yes 18
 No 9
Whether complicated by extrahepatic metastasis
 Yes 16
 No 11
 Number of interventional treatment sessions (range) 2.44 ± 1.58 (1–6)
  1. ER/PR estrogen receptor/progesterone receptor